intoDNA News

Check out news and press releases or download our publications.
Read More
image

intoDNA News

hero image
Check out news and press releases or download our publications.
Read More
Feb 07, 2024

Magda Kordon-Kiszala speaks about the shortcomings of γH2AX at the DDR Inhibitors Summit 2024

The proprietary fluorescence-based platform technology STRIDE™ outperforms non-specific and non-quantifiable, but well-established approaches to DNA damage analysis such as gamma-H2AX assay. 
Keep Reading
All news
Feb 07, 2024

Magda Kordon-Kiszala speaks about the shortcomings of γH2AX at the DDR Inhibitors Summit 2024

Keep Reading
Nov 17, 2023

STRIDE validated in human in vivo samples in collaboration with AstraZeneca

Keep Reading
Nov 03, 2023

intoDNA exhibits at SITC 2023, the premier cancer immunotherapy conference

Keep Reading
Jul 11, 2023

intoDNA to participate in the 2nd Annual Targeted Radiopharmaceuticals Summit US (TRP)

Keep Reading
May 18, 2023

intoDNA to exhibit at the BIO International Convention 2023

Keep Reading
Mar 28, 2023

intoDNA to present and exhibit at the American Association for Cancer Research Annual Meeting 2023

Keep Reading
Jul 19, 2022

intoDNA joins the BioInMed initiative gathering key medical biotechnology companies in Poland

Keep Reading
Apr 28, 2022

Magda Kordon as an invited speaker at the DNA Repair/Replication Structures & Cancer Conference

Keep Reading
Mar 25, 2022

STRIDE Workshop at the PARP Meeting in Cold Spring Harbor Lab

Keep Reading
Feb 24, 2022

Magda Kordon, CEO attending the 2022 Gordon Research Conference on DNA Damage, Mutation and Cancer

Keep Reading
Jan 24, 2022

intoDNA to present at the 5th Annual DDR, ATR and PARP Inhibitors Summit

Keep Reading
Dec 20, 2021

intoDNA awarded funding from the Polish Agency for Enterprise Development

Keep Reading
Sep 28, 2021

STRIDE featured in Frontiers by our partners at Universitat Autònoma de Barcelona

Keep Reading
See more articles